[癌症患者感染的处理]。

4区医学 Q4 Medicine

Onkologe Pub Date : 2022-01-01 Epub Date: 2022-03-15 DOI:10.1007/s00761-022-01120-z

Annika Yanina Classen, Michael Sandherr, Jörg Janne Vehreschild, Marie von Lilienfeld-Toal

{"title":"[癌症患者感染的处理]。","authors":"Annika Yanina Classen, Michael Sandherr, Jörg Janne Vehreschild, Marie von Lilienfeld-Toal","doi":"10.1007/s00761-022-01120-z","DOIUrl":null,"url":null,"abstract":"Patients with cancer are at increased risk of infection due to disease-associated or therapy-induced immunosuppression. Taking into account globally increasing antimicrobial resistance rates and negative effects associated with antibiotic treatments, the effective, appropriate and guideline-conform use of anti-infectives must be promoted in this clinical setting. The application of antibacterial prophylaxis should be limited to high-risk patients. Infection diagnostics and therapeutic strategies differ depending on the extent of expected immunosuppression and the patient's individual risk factors.","PeriodicalId":54684,"journal":{"name":"Onkologe","volume":" ","pages":"349-360"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922085/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Management of infections in patients with cancer].\",\"authors\":\"Annika Yanina Classen, Michael Sandherr, Jörg Janne Vehreschild, Marie von Lilienfeld-Toal\",\"doi\":\"10.1007/s00761-022-01120-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Patients with cancer are at increased risk of infection due to disease-associated or therapy-induced immunosuppression. Taking into account globally increasing antimicrobial resistance rates and negative effects associated with antibiotic treatments, the effective, appropriate and guideline-conform use of anti-infectives must be promoted in this clinical setting. The application of antibacterial prophylaxis should be limited to high-risk patients. Infection diagnostics and therapeutic strategies differ depending on the extent of expected immunosuppression and the patient's individual risk factors.\",\"PeriodicalId\":54684,\"journal\":{\"name\":\"Onkologe\",\"volume\":\" \",\"pages\":\"349-360\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922085/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onkologe\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00761-022-01120-z\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/3/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onkologe","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00761-022-01120-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

由于疾病相关或治疗诱导的免疫抑制，癌症患者感染的风险增加。考虑到全球不断增加的抗菌素耐药率和与抗生素治疗相关的负面影响，必须在这种临床环境中促进有效、适当和符合指南的抗感染药物使用。抗菌预防的应用应限于高危患者。感染诊断和治疗策略的不同取决于预期的免疫抑制程度和患者的个体危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

[Management of infections in patients with cancer].

查看原文本刊更多论文

[Management of infections in patients with cancer].

Patients with cancer are at increased risk of infection due to disease-associated or therapy-induced immunosuppression. Taking into account globally increasing antimicrobial resistance rates and negative effects associated with antibiotic treatments, the effective, appropriate and guideline-conform use of anti-infectives must be promoted in this clinical setting. The application of antibacterial prophylaxis should be limited to high-risk patients. Infection diagnostics and therapeutic strategies differ depending on the extent of expected immunosuppression and the patient's individual risk factors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Onkologe 医学-肿瘤学

CiteScore

0.40

自引率

0.00%

发文量

101

审稿时长

4-8 weeks

期刊介绍： Der Onkologe deals with relevant issues concerning the diagnosis and therapy of oncological diseases. Special emphasis is placed on oncology’s interfaces with the fields of internal medicine, radiology and surgery. This interdisciplinary journal addresses the needs of researchers and doctors working in the field of oncology. The core of each issue consists of comprehensive reviews on a specific topical issue. Here the focus is on providing evidenced based information on diagnostics and therapy relevant for daily practice. After the topics are selected by an independent editorial board, established experts prepare the articles for each issue. Contributions under the rubric ''Continuing Medical Education'' present the verified results of scientific research and their integration into daily practice.